FIGURE

Fig. 3

ID

ZDB-FIG-150921-42

Publication

Sun et al., 2015 - Conserved Noncoding Sequences Regulate lhx5 Expression in the Zebrafish Forebrain

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

CNS2 contains hypothalamic enhancer activity and responses to FGF signaling.

(A-B) Double in situ hybridization results indicate CNS2 contains hypothalamic enhancer activity. The hypothalamic marker nkx2.1a and nkx2.2b are stained in dark blue, reporter egfp stained in red. (C-D) SU5402 treatment severely reduces CNS2 activity. Vehicle DMSO treated embryos show restricted hypothalamic EGFP reporter expression (pointed by the arrow in C). Embryos treated with the FGF signaling inhibitor SU5402 during the segmentation stage (10-24hpf) show minimal EGFP signals in the hypothalamic region (arrow in D, n = 48/55). (E-F) SU5402 treatment down-regulates endogenous lhx5 expression in the hypothalamic region. Endogenous lhx5 shows robust expression in the hypothalamic region (pointed by the arrow in E). SU5402 treatment during the segmentation stage down-regulates lhx5 expression in the hypothalamic region (arrow in F, n = 25/28). (G) Multiple sequence alignments of the CNS2 region in the five teleost species. The identified FGF downstream factor Pea3 binding site is highlighted in blue. Lateral view of the forebrain regions of embryos at 24 hpf (A-F), anterior to the left. Scale bar: 40µm in A-B; 50µm in C-D.

Expression Data

Genes:	EGFP lhx5 nkx2.2b nkx2.4b
Fish:	WT zf763Tg zf766Tg
Condition:	chemical treatment: SU5402
Anatomical Term:	hypothalamus
Stage:	Prim-5

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	WT zf766Tg
Condition:	chemical treatment: SU5402
Observed In:	hypothalamus
Stage:	Prim-5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS One